338038 <common-name>2-[[5-(3,5-dibromo-2-hydroxyphenyl)-4-(4-methylphenyl)-1,2,4-triazol-3-yl]sulfanyl]-n-(phenylcarbamoyl)acetamide</common-name> <description>2-[[5-(3,5-dibromo-2-hydroxyphenyl)-4-(4-methylphenyl)-1,2,4-triazol-3-yl]sulfanyl]-n-(phenylcarbamoyl)acetamide is a chemical compound with the formula C24H19Br2N5O3S. With an average molecular weight of 617.30 g/mol, 2-[[5-(3,5-dibromo-2-hydroxyphenyl)-4-(4-methylphenyl)-1,2,4-triazol-3-yl]sulfanyl]-n-(phenylcarbamoyl)acetamide is a heavy molecule.</description> <cas>97399-34-3</cas> <pubchem-id>135849850</pubchem-id> <chemical-formula>C24H19Br2N5O3S</chemical-formula> <weight>617.3</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-30T21:04:13Z</created-at> <updated-at type="dateTime">2026-08-30T21:04:13Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC1=CC=C(C=C1)N2C(=NN=C2SCC(=O)NC(=O)NC3=CC=CC=C3)C4=C(C(=CC(=C4)Br)Br)O</moldb-smiles> <moldb-formula>C24H19Br2N5O3S</moldb-formula> <moldb-inchi>InChI=1S/C24H19Br2N5O3S/c1-14-7-9-17(10-8-14)31-22(18-11-15(25)12-19(26)21(18)33)29-30-24(31)35-13-20(32)28-23(34)27-16-5-3-2-4-6-16/h2-12,33H,13H2,1H3,(H2,27,28,32,34)</moldb-inchi> <moldb-inchikey>VHDFAPJYFPGGDO-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">614.95754</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>6</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM333931</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>2-[[5-(3,5-dibromo-2-hydroxyphenyl)-4-(4-methylphenyl)-1,2,4-triazol-3-yl]sulfanyl]-n-(phenylcarbamoyl)acetamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Benzenoids</superklass> <klass>Benzene and substituted derivatives</klass> <subklass>N-phenylureas</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0288467</sync-id> <structure-inchikey>VHDFAPJYFPGGDO-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>4000200000800000000800000000010000000100200000005000020000000000000000000004008000002084000000000000000800000000000000000000000000000000000000000000080020000000000001000200800010000000008000010000004000000000100000000400000100000000000000000000000000000040000400800000010000000080080000000100000000000000000000000000004000000020000000080000000000000000408000000000002c00000000000000000000002000000100000000000000000000002000000200000000000000008140000000000040000000000480080000010000000640000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAjAAAAJgAAAIABBgBgAAAAAQMGQCgAAAAD BAZAaAAAAAMDAQZAaAAAAAMDAQZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMB B0AoAAAAAwMGQCgAAAADBAdAKAAAAAMDB0AoAAAAAwMGQCgAAAADBBAAIAAA AAIGAGAAAAACAgYAKAAAAAMECAAoAAAAAwIHAGgAAAADAgEGACgAAAADBAgA KAAAAAMCBwBoAAAAAwIBBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEGQGgA AAADAwEGQGgAAAADAwEGQGgAAAADAwEGQCgAAAADBAZAKAAAAAMEBkAoAAAA AwQGQGgAAAADAwEGQCgAAAADBAZAaAAAAAMDASMAIAAAAAEjACAAAAABCABo AAAAAwEBCwABAAECaAwCA2gMAwRoDAQFaAwFBmgMBAcgBwhoDAgJaAwJCmgM CgtoDAsMAAwNAA0OAA4PKAIOECAQESAREigCERMgExQgFBVoDBUWaAwWF2gM FxhoDBgZaAwIGiAaG2gMGxxoDBwdaAwdHmgMHh9oDB4gABwhABsiIAYBaAwL B2gMGRRoDB8aaAxCBAAAAAYBBgUEAwIFCQgHCwoGFRYXGBkUBhscHR4fGhcE AAAAAAAAABY= </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:38:56Z</structure-indexed-at> </compound>